Session details
6 pm, Thursday 22 June 2017
Hall 1 East, Engadine Community Centre
1034–1036 Old Princes Highway, Engadine NSW
The CEO is hosting a Community Information Session on the ANSTO licence application for Nuclear Medicine Molybdenum-99 Facility. The purpose of this Community Information Session is to:
- outline the process ARPANSA will use to assess and decide the application including the way in which the Agency will seek and take into account public submissions
- inform you of the nature and details of the application
- address issues raised through public submissions
- record any further issues that may arise on the night as new submissions.
